<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="JVirol. JVirology Journal1743-422XBioMed CentralLondon pmcid: 72862161343 doi: 10.1186/s12985-020-01343-9 : Review" exact="Hepatitis" post="E virus infection during pregnancy WuChunchenWuXiaoxuehttp://orcid.org/0000-0002-8912-9921XiaJianboxjb915@126.com[], grid.33199.310000 0004 0368"/>
 <result pre="Journal1743-422XBioMed CentralLondon pmcid: 72862161343 doi: 10.1186/s12985-020-01343-9 : Review Hepatitis E" exact="virus infection" post="during pregnancy WuChunchenWuXiaoxuehttp://orcid.org/0000-0002-8912-9921XiaJianboxjb915@126.com[], grid.33199.310000 0004 0368 7223Department of Laboratory"/>
 <result pre="CentralLondon pmcid: 72862161343 doi: 10.1186/s12985-020-01343-9 : Review Hepatitis E virus" exact="infection" post="during pregnancy WuChunchenWuXiaoxuehttp://orcid.org/0000-0002-8912-9921XiaJianboxjb915@126.com[], grid.33199.310000 0004 0368 7223Department of Laboratory"/>
 <result pre="stated in a credit line to the data. Abstract Background" exact="Hepatitis" post="E virus (HEV) generally causes self-limiting viral hepatitis. However,"/>
 <result pre="data. Abstract Background Hepatitis E virus (HEV) generally causes self-limiting" exact="viral hepatitis." post="However, in pregnant women, HEV infection can be severe"/>
 <result pre="generally causes self-limiting viral hepatitis. However, in pregnant women, HEV" exact="infection" post="can be severe and has been associated with up"/>
 <result pre="up to 30% mortality in the third trimester. Additionally, HEV" exact="infection" post="in pregnancy is also associated with high rates of"/>
 <result pre="blood transfusion route. An altered immune status, hormonal levels, and" exact="viral" post="factors may be related to the severity of the"/>
 <result pre="determined. Conclusion This review summarizes the current knowledge about HEV" exact="infection" post="during pregnancy and focuses on the epidemiology, clinical manifestations,"/>
 <result pre="underlying severe liver injury, and management and prevention of HEV" exact="infection" post="during pregnancy. Considering that HEV infection during pregnancy may"/>
 <result pre="and prevention of HEV infection during pregnancy. Considering that HEV" exact="infection" post="during pregnancy may result in poor outcomes, screening for"/>
 <result pre="may result in poor outcomes, screening for and monitoring HEV" exact="infection" post="early in pregnancy should be taken into account. In"/>
 <result pre="pathogenesis will help to develop potential treatment strategies targeting HEV" exact="infection" post="in pregnancy. Keywords Hepatitis E virus (HEV) Hepatitis E"/>
 <result pre="develop potential treatment strategies targeting HEV infection in pregnancy. Keywords" exact="Hepatitis" post="E virus (HEV) Hepatitis E Pregnancy Background Hepatitis E"/>
 <result pre="targeting HEV infection in pregnancy. Keywords Hepatitis E virus (HEV)" exact="Hepatitis" post="E Pregnancy Background Hepatitis E virus (HEV) is a"/>
 <result pre="infection in pregnancy. Keywords Hepatitis E virus (HEV) Hepatitis E" exact="Pregnancy" post="Background Hepatitis E virus (HEV) is a hepatotropic infectious"/>
 <result pre="pregnancy. Keywords Hepatitis E virus (HEV) Hepatitis E Pregnancy Background" exact="Hepatitis" post="E virus (HEV) is a hepatotropic infectious agent that"/>
 <result pre="E Pregnancy Background Hepatitis E virus (HEV) is a hepatotropic" exact="infectious" post="agent that generally causes self-limiting acute hepatitis in healthy"/>
 <result pre="(HEV) is a hepatotropic infectious agent that generally causes self-limiting" exact="acute hepatitis" post="in healthy adults and chronic hepatitis in immunocompromised individuals"/>
 <result pre="is a hepatotropic infectious agent that generally causes self-limiting acute" exact="hepatitis" post="in healthy adults and chronic hepatitis in immunocompromised individuals"/>
 <result pre="that generally causes self-limiting acute hepatitis in healthy adults and" exact="chronic hepatitis" post="in immunocompromised individuals [1]. Annually, there are an estimated"/>
 <result pre="generally causes self-limiting acute hepatitis in healthy adults and chronic" exact="hepatitis" post="in immunocompromised individuals [1]. Annually, there are an estimated"/>
 <result pre="there are an estimated 20 million HEV infections, 3.3 million" exact="symptomatic" post="hepatitis E cases, and 60,000 deaths worldwide [1, 2]."/>
 <result pre="are an estimated 20 million HEV infections, 3.3 million symptomatic" exact="hepatitis" post="E cases, and 60,000 deaths worldwide [1, 2]. In"/>
 <result pre="manifestations, including pancreatitis, neurological symptoms, hematological disorders, glomerulonephritis, and mixed" exact="cryoglobulinemia" post="have been associated with HEV infection [1, 3]. HEV"/>
 <result pre="disorders, glomerulonephritis, and mixed cryoglobulinemia have been associated with HEV" exact="infection" post="[1, 3]. HEV is classified into 8 major genotypes,"/>
 <result pre="and 4 (HEV-4) are zoonotic and are contracted through the" exact="consumption" post="of undercooked pork and wild boar meat [5]. Although"/>
 <result pre="shellfish, deer, and rabbits can serve as a source of" exact="infection" post="[4, 6–9]. Therefore, HEV-1 and HEV-2 are often associated"/>
 <result pre="countries and are associated with sporadic and clustered cases of" exact="hepatitis" post="E in these regions [1, 4]. In recent years,"/>
 <result pre="industrialized countries [1, 12]. Current therapeutics used to treat HEV" exact="infection" post="include the nucleoside analog ribavirin and interferon-α (IFN-α). Ribavirin"/>
 <result pre="Ribavirin therapy can be fairly efficient in most cases of" exact="chronic hepatitis" post="E [1, 2, 13, 14]. In some specific situations,"/>
 <result pre="therapy can be fairly efficient in most cases of chronic" exact="hepatitis" post="E [1, 2, 13, 14]. In some specific situations,"/>
 <result pre="against HEV, particularly for pregnant women [1, 15]. A recombinant" exact="hepatitis" post="E vaccine, HEV 239, has been demonstrated to be"/>
 <result pre="to be well tolerated and effective in the prevention of" exact="hepatitis" post="E in China; however, it is currently only approved"/>
 <result pre="and is not yet available elsewhere [2, 16, 17]. HEV" exact="infection" post="can cause fulminant hepatitis failure (FHF), especially in pregnant"/>
 <result pre="available elsewhere [2, 16, 17]. HEV infection can cause fulminant" exact="hepatitis" post="failure (FHF), especially in pregnant women, with a mortality"/>
 <result pre="summary of the current knowledge regarding HEV and highlight HEV" exact="infection" post="during pregnancy, which has been poorly understood until now"/>
 <result pre="transmitted via different routes and possess distinct characteristics in the" exact="viral" post="life cycle [1, 12]. The HEV genome is a"/>
 <result pre="subgenomic RNA [34]. ORF2 encodes both glycosylated ORF2 antigen and" exact="viral" post="capsid protein [35, 36]. ORF3 encodes a small multifunctional"/>
 <result pre="[12, 17] (Fig. 1). Fig. 1 Schematic description of the" exact="hepatitis" post="E virus (HEV) genome and viral proteins. The HEV"/>
 <result pre="Schematic description of the hepatitis E virus (HEV) genome and" exact="viral" post="proteins. The HEV genome is a single-stranded, positive-sense, linear"/>
 <result pre="RNA that is approximately 2.2 kb in length. ORF2 encodes a" exact="viral" post="capsid protein that is required for viral entry, assembly"/>
 <result pre="ORF2 encodes a viral capsid protein that is required for" exact="viral" post="entry, assembly and immunogenicity. ORF3 encodes a small multifunctional"/>
 <result pre="numerous cellular pathways The study of HEV replication has been" exact="limited" post="to efficient cell culture systems, and replication within the"/>
 <result pre="essential for binding to an unknown cellular receptor to initiate" exact="viral" post="entry [37]. The eHEV may have a distinct mechanism"/>
 <result pre="entry [37]. The eHEV may have a distinct mechanism of" exact="viral" post="entry, considering that it is enveloped and capsid protein"/>
 <result pre="entering the target cell, the virus is uncoated, and the" exact="viral" post="RNA genome is released into the cytoplasm. Following this,"/>
 <result pre="viral RNA genome is released into the cytoplasm. Following this," exact="viral" post="nonstructural proteins are translated from ORF1 [39]. A negative-sense"/>
 <result pre="viral nonstructural proteins are translated from ORF1 [39]. A negative-sense" exact="intermediate" post="RNA is synthesized based on the positive-sense viral RNA"/>
 <result pre="A negative-sense intermediate RNA is synthesized based on the positive-sense" exact="viral" post="RNA genome with the help of RdRp; this product,"/>
 <result pre="turn, serves as a template to produce 7.2-kb positive-sense progeny" exact="viral" post="RNA as well as 2.2-kb subgenomic RNA [31, 40]."/>
 <result pre="released by mechanisms still unclear [17, 41]. Epidemiology of HEV" exact="infection" post="in pregnancy HEV infection is associated with high incidence"/>
 <result pre="unclear [17, 41]. Epidemiology of HEV infection in pregnancy HEV" exact="infection" post="is associated with high incidence and mortality (principally due"/>
 <result pre="field study carried out by Khuroo et al. showed that" exact="hepatitis" post="E developed in 36 (17.3%) of 208 pregnant women,"/>
 <result pre="developed in 8 (22.2%) of the 36 pregnant women with" exact="hepatitis" post="E. In contrast, none of the nonpregnant women showed"/>
 <result pre="the first time, this study revealed that the incidence of" exact="hepatitis" post="E and fulminant rates were higher in pregnant women"/>
 <result pre="women than nonpregnant women and men. In another study, HEV" exact="infection" post="was observed in 57.5 and 46% of pregnant and"/>
 <result pre="Indian subcontinent reported that the prevalence rate of HEV in" exact="acute" post="viral hepatitis during pregnancy ranged from 58 to 86%"/>
 <result pre="subcontinent reported that the prevalence rate of HEV in acute" exact="viral hepatitis" post="during pregnancy ranged from 58 to 86% [44–46]. HEV"/>
 <result pre="reported that the prevalence rate of HEV in acute viral" exact="hepatitis" post="during pregnancy ranged from 58 to 86% [44–46]. HEV"/>
 <result pre="hepatitis during pregnancy ranged from 58 to 86% [44–46]. HEV" exact="infection" post="can result in up to 30% mortality among pregnant"/>
 <result pre="most prevalent genotypes in developing countries [10, 42]. Additionally, HEV" exact="infection" post="in pregnancy is also associated with high rates of"/>
 <result pre="47, 48]. The frequent occurrence of other complications, such as" exact="disseminated intravascular coagulation" post="(DIC), is also associated with HEV infection in pregnant"/>
 <result pre="as disseminated intravascular coagulation (DIC), is also associated with HEV" exact="infection" post="in pregnant women [4]. For industrialized countries, there are"/>
 <result pre="HEV-2, HEV-3 and HEV-4 do not appear to cause fatal" exact="infections" post="with fulminant hepatitis in pregnant women [10, 49]. However,"/>
 <result pre="HEV-4 do not appear to cause fatal infections with fulminant" exact="hepatitis" post="in pregnant women [10, 49]. However, considering that the"/>
 <result pre="for HEV, and HEV-4 is currently the dominant cause of" exact="hepatitis" post="E [52, 53]. HEV infection has considerable potential for"/>
 <result pre="currently the dominant cause of hepatitis E [52, 53]. HEV" exact="infection" post="has considerable potential for transmission in pregnant women in"/>
 <result pre="[56]. These results may reflect the varied seroprevalence of HEV" exact="infection" post="in different areas of China. In addition, anti-HEV IgM"/>
 <result pre="seropositivity occurs first and persists for 3–5 months after the initial" exact="disease" post="onset [57, 58]. Shortly after the appearance of IgM,"/>
 <result pre="of IgM, IgG antibodies develop seropositivity and persist throughout the" exact="acute" post="and convalescent phases, maintaining high levels for a year"/>
 <result pre="does not necessarily reflect current HEV-positivity and may result from" exact="infection" post="and clearance prior to becoming pregnant. Furthermore, besides the"/>
 <result pre="strain exclusively identified in those with a history of HEV" exact="infection" post="was HEV-4 [61], which seemingly coincides with the fact"/>
 <result pre="and maternal and fetal outcomes. The combination of other virus" exact="infections" post="with HEV infection may enhance the mortality rate. It"/>
 <result pre="fetal outcomes. The combination of other virus infections with HEV" exact="infection" post="may enhance the mortality rate. It is estimated that"/>
 <result pre="mortality rate. It is estimated that in patients suffering from" exact="chronic" post="liver disease (e.g., hepatitis B virus (HBV) infection), these"/>
 <result pre="rate. It is estimated that in patients suffering from chronic" exact="liver disease" post="(e.g., hepatitis B virus (HBV) infection), these infections often"/>
 <result pre="It is estimated that in patients suffering from chronic liver" exact="disease" post="(e.g., hepatitis B virus (HBV) infection), these infections often"/>
 <result pre="estimated that in patients suffering from chronic liver disease (e.g.," exact="hepatitis" post="B virus (HBV) infection), these infections often progress to"/>
 <result pre="chronic liver disease (e.g., hepatitis B virus (HBV) infection), these" exact="infections" post="often progress to liver failure, with a mortality rate"/>
 <result pre="hepatitis B virus (HBV) infection), these infections often progress to" exact="liver failure," post="with a mortality rate of 27% [64, 65]. Our"/>
 <result pre="data suggested that there were increased rates of other virus" exact="infections" post="in both anti-HEV IgM- and anti-HEV IgG-positive pregnant women."/>
 <result pre="IgM- and anti-HEV IgG-positive pregnant women. In pregnant women with" exact="chronic hepatitis" post="C virus (HCV) coinfection, a marked increase in anti-HEV"/>
 <result pre="and anti-HEV IgG-positive pregnant women. In pregnant women with chronic" exact="hepatitis" post="C virus (HCV) coinfection, a marked increase in anti-HEV"/>
 <result pre="efforts are needed to investigate the epidemiology of other virus" exact="infections" post="combined with HEV infection in pregnancy. Clinical manifestations Acute"/>
 <result pre="investigate the epidemiology of other virus infections combined with HEV" exact="infection" post="in pregnancy. Clinical manifestations Acute hepatitis E According to"/>
 <result pre="virus infections combined with HEV infection in pregnancy. Clinical manifestations" exact="Acute" post="hepatitis E According to previous data, the clinical manifestations"/>
 <result pre="infections combined with HEV infection in pregnancy. Clinical manifestations Acute" exact="hepatitis" post="E According to previous data, the clinical manifestations of"/>
 <result pre="E According to previous data, the clinical manifestations of HEV" exact="infection" post="are different, varying from asymptomatic to fulminant hepatic failure."/>
 <result pre="from asymptomatic to fulminant hepatic failure. HEV usually causes an" exact="acute" post="self-limiting hepatitis. The prodromal phase lasts up to 1"/>
 <result pre="and vomiting. Subsequently, a series of typical symptoms related to" exact="acute" post="icteric hepatitis, including jaundice, darkened urine, and pale stools"/>
 <result pre="pale stools may occur, similar to those seen in HAV" exact="infection" post="[67]. However, compared with HAV, patients with HEV are"/>
 <result pre="with HAV, patients with HEV are known to have prolonged" exact="cholestasis" post="[68]. Mansuy et al. [69] studied 62 confirmed cases"/>
 <result pre="[68]. Mansuy et al. [69] studied 62 confirmed cases of" exact="acute hepatitis" post="E over a 5 year period in south-west France and"/>
 <result pre="Mansuy et al. [69] studied 62 confirmed cases of acute" exact="hepatitis" post="E over a 5 year period in south-west France and"/>
 <result pre="of patients became jaundiced. In fact, the jaundice rate of" exact="acute" post="HEV infection is likely much lower given that most"/>
 <result pre="became jaundiced. In fact, the jaundice rate of acute HEV" exact="infection" post="is likely much lower given that most cases are"/>
 <result pre="the jaundice rate of acute HEV infection is likely much" exact="lower" post="given that most cases are not recognized or diagnosed."/>
 <result pre="levels can also rise [10, 70]. In immunocompetent individuals, the" exact="infection" post="and symptoms typically resolve spontaneously within 4–6 weeks [71]. Compared"/>
 <result pre="do not differ in pregnant women at first [72]. However," exact="acute" post="liver failure can develop rapidly in patients with HEV"/>
 <result pre="not differ in pregnant women at first [72]. However, acute" exact="liver failure" post="can develop rapidly in patients with HEV infection during"/>
 <result pre="acute liver failure can develop rapidly in patients with HEV" exact="infection" post="during pregnancy. Several complications of fulminant hepatic failure, including"/>
 <result pre="infection during pregnancy. Several complications of fulminant hepatic failure, including" exact="cerebral edema," post="DIC, and encephalopathy, appear to occur at a higher"/>
 <result pre="and encephalopathy, appear to occur at a higher rate [18]." exact="Hepatic" post="encephalopathy is the most common cause of death among"/>
 <result pre="encephalopathy, appear to occur at a higher rate [18]. Hepatic" exact="encephalopathy" post="is the most common cause of death among these"/>
 <result pre="or newborn have also been observed in these patients [72]." exact="Chronic" post="hepatitis E Chronic HEV infection is defined as an"/>
 <result pre="newborn have also been observed in these patients [72]. Chronic" exact="hepatitis" post="E Chronic HEV infection is defined as an HEV"/>
 <result pre="also been observed in these patients [72]. Chronic hepatitis E" exact="Chronic" post="HEV infection is defined as an HEV viremia for"/>
 <result pre="observed in these patients [72]. Chronic hepatitis E Chronic HEV" exact="infection" post="is defined as an HEV viremia for more than"/>
 <result pre="transplantation or stem cell transplantation [75–77] and those with human" exact="immunodeficiency" post="virus (HIV) infection [78, 79] or with hematological malignancy"/>
 <result pre="cell transplantation [75–77] and those with human immunodeficiency virus (HIV)" exact="infection" post="[78, 79] or with hematological malignancy [80–82], chronic HEV"/>
 <result pre="with human immunodeficiency virus (HIV) infection [78, 79] or with" exact="hematological malignancy" post="[80–82], chronic HEV infection may develop. This disease course"/>
 <result pre="virus (HIV) infection [78, 79] or with hematological malignancy [80–82]," exact="chronic" post="HEV infection may develop. This disease course of chronic"/>
 <result pre="infection [78, 79] or with hematological malignancy [80–82], chronic HEV" exact="infection" post="may develop. This disease course of chronic infection has"/>
 <result pre="with hematological malignancy [80–82], chronic HEV infection may develop. This" exact="disease" post="course of chronic infection has mainly been reported for"/>
 <result pre="[80–82], chronic HEV infection may develop. This disease course of" exact="chronic" post="infection has mainly been reported for HEV-3 and 4,"/>
 <result pre="chronic HEV infection may develop. This disease course of chronic" exact="infection" post="has mainly been reported for HEV-3 and 4, leading"/>
 <result pre="mainly been reported for HEV-3 and 4, leading to life-threatening" exact="liver fibrosis" post="and cirrhosis [75, 80, 83–85]. It has been reported"/>
 <result pre="for HEV-3 and 4, leading to life-threatening liver fibrosis and" exact="cirrhosis" post="[75, 80, 83–85]. It has been reported that HEV-3"/>
 <result pre="80, 83–85]. It has been reported that HEV-3 can cause" exact="acute hepatitis" post="E in pregnant women, followed by rapid clearance without"/>
 <result pre="83–85]. It has been reported that HEV-3 can cause acute" exact="hepatitis" post="E in pregnant women, followed by rapid clearance without"/>
 <result pre="any signs of severe courses [50, 51]. Extrahepatic manifestations of" exact="hepatitis" post="E Acute or chronic or previous HEV infection can"/>
 <result pre="of severe courses [50, 51]. Extrahepatic manifestations of hepatitis E" exact="Acute" post="or chronic or previous HEV infection can cause extrahepatic"/>
 <result pre="severe courses [50, 51]. Extrahepatic manifestations of hepatitis E Acute" exact="or chronic" post="or previous HEV infection can cause extrahepatic manifestations [86,"/>
 <result pre="courses [50, 51]. Extrahepatic manifestations of hepatitis E Acute or" exact="chronic" post="or previous HEV infection can cause extrahepatic manifestations [86,"/>
 <result pre="manifestations of hepatitis E Acute or chronic or previous HEV" exact="infection" post="can cause extrahepatic manifestations [86, 87], which include a"/>
 <result pre="range of neurological symptoms and impaired kidney function associated with" exact="cryoglobulinemia" post="[84, 88]. Other extrahepatic manifestations documented in the literature"/>
 <result pre="[84, 88]. Other extrahepatic manifestations documented in the literature include" exact="acute" post="thyroiditis [89], thrombocytopenia [90], and acute pancreatitis [91]. However,"/>
 <result pre="88]. Other extrahepatic manifestations documented in the literature include acute" exact="thyroiditis" post="[89], thrombocytopenia [90], and acute pancreatitis [91]. However, it"/>
 <result pre="extrahepatic manifestations documented in the literature include acute thyroiditis [89]," exact="thrombocytopenia" post="[90], and acute pancreatitis [91]. However, it remains uncertain"/>
 <result pre="in the literature include acute thyroiditis [89], thrombocytopenia [90], and" exact="acute" post="pancreatitis [91]. However, it remains uncertain whether extrahepatic manifestations"/>
 <result pre="the literature include acute thyroiditis [89], thrombocytopenia [90], and acute" exact="pancreatitis" post="[91]. However, it remains uncertain whether extrahepatic manifestations of"/>
 <result pre="uncertain whether extrahepatic manifestations of HEV are attributed to direct" exact="infection" post="of extrahepatic tissues or cross-reactive immune responses. As of"/>
 <result pre="the molecular mechanism of extrahepatic tissue injury caused by HEV" exact="infection" post="is unclear, and the roles of pathogenic genotypes and"/>
 <result pre="be identified. Mechanisms underlying severe liver injury due to HEV" exact="infection" post="during pregnancy The mechanisms of severe liver injury due"/>
 <result pre="pregnancy The mechanisms of severe liver injury due to HEV" exact="infection" post="in pregnant women are unknown. According to previous studies,"/>
 <result pre="of pregnant women, such as altered immunity, hormone levels, and" exact="viral" post="factors, such as HEV genome heterogeneity and variants, may"/>
 <result pre="and variants, may be related to the severity of the" exact="disease" post="[19, 42] (Fig. 2). Fig. 2 Mechanisms underlying severe"/>
 <result pre="Fig. 2 Mechanisms underlying severe liver injury due to HEV" exact="infection" post="in pregnancy. The altered status of immunity, hormone levels"/>
 <result pre="in pregnancy. The altered status of immunity, hormone levels and" exact="viral" post="factors may be related to the severity of the"/>
 <result pre="factors may be related to the severity of the disease." exact="Viral" post="factors include HEV genome heterogeneity and variants, as well"/>
 <result pre="factors include HEV genome heterogeneity and variants, as well as" exact="viral" post="proteins, such as MFP, encoded by HEV ORF3, may"/>
 <result pre="as nutritional status, may also influence the severity of HEV" exact="infection" post="in pregnant women Immunity During pregnancy, the maternal immune"/>
 <result pre="considerably complex. A longitudinal study showed that compared to the" exact="postpartum" post="period, the number and activity of natural killer (NK)"/>
 <result pre="pregnancy, while monocytes, granulocytes, and dendritic cells (DCs) increase in" exact="peripheral" post="blood during pregnancy [93], suggesting that adaptive immune responses"/>
 <result pre="the pregnant mother and the fetus may be protected from" exact="susceptibility to" post="initial infection. However, once infected, pathogen clearance may be"/>
 <result pre="impaired, resulting in increased severity of the disease, especially for" exact="infections" post="such as influenza, cytomegalovirus (CMV), severe acute respiratory syndrome"/>
 <result pre="disease, especially for infections such as influenza, cytomegalovirus (CMV), severe" exact="acute" post="respiratory syndrome (SARS), varicella- zoster, malaria, and herpes simplex"/>
 <result pre="especially for infections such as influenza, cytomegalovirus (CMV), severe acute" exact="respiratory" post="syndrome (SARS), varicella- zoster, malaria, and herpes simplex virus"/>
 <result pre="for infections such as influenza, cytomegalovirus (CMV), severe acute respiratory" exact="syndrome" post="(SARS), varicella- zoster, malaria, and herpes simplex virus (HSV)"/>
 <result pre="(CMV), severe acute respiratory syndrome (SARS), varicella- zoster, malaria, and" exact="herpes" post="simplex virus (HSV) infection, in which cell-mediated immunity is"/>
 <result pre="host of important immune elements operates during pregnancy to regulate" exact="systemic" post="Th1 responses, including higher frequencies of T regulatory cells."/>
 <result pre="The immunological mechanisms underlying severe liver injury due to HEV" exact="infection" post="in pregnancy are not yet well understood. It has"/>
 <result pre="and NKT cells in the liver as well as in" exact="peripheral" post="circulation [86, 101–103]. In HEV-positive pregnant patients with FHF,"/>
 <result pre="CD8 + T cell counts were higher and CD4+/CD8+ ratios were significantly" exact="lower" post="than those in HEV-negative pregnant women or in controls"/>
 <result pre="with HEV infection, its effect on the severity of HEV" exact="infection" post="is unknown [86]. Impaired monocyte-macrophage functions and defective Toll-like"/>
 <result pre="innate immune responses may contribute to the development and severity" exact="of liver" post="injury due to HEV infection in pregnancy [86, 105]."/>
 <result pre="the development and severity of liver injury due to HEV" exact="infection" post="in pregnancy [86, 105]. In pregnant patients with FHF"/>
 <result pre="much higher than those in nonpregnant women and women with" exact="acute" post="viral hepatitis (AVH) without FHF. An analysis of the"/>
 <result pre="higher than those in nonpregnant women and women with acute" exact="viral hepatitis" post="(AVH) without FHF. An analysis of the NF-κB complex"/>
 <result pre="than those in nonpregnant women and women with acute viral" exact="hepatitis" post="(AVH) without FHF. An analysis of the NF-κB complex"/>
 <result pre="folic acid, may also influence the immune response to HEV" exact="infection" post="in pregnant women [108–111]. Hormonal factors As pregnancy progresses,"/>
 <result pre="pregnant FHF patients than in HEV-negative patients or controls [104]." exact="Increased" post="estradiol in the serum of HEV-infected pregnant women promoted"/>
 <result pre="Increased estradiol in the serum of HEV-infected pregnant women promoted" exact="viral" post="replication [114, 115], which may be associated with poor"/>
 <result pre="fetal mortality through placental dysfunction in pregnant women with HEV" exact="infection" post="[116]. Many studies have shown that hormonal factors play"/>
 <result pre="found to be decreased in women with FHF [86, 117]." exact="Viral" post="factors Genome heterogeneity and HEV variants According to the"/>
 <result pre="In contrast, the association of increased incidence and severity of" exact="hepatitis" post="E in pregnant women infected with HEV-1 or HEV-2"/>
 <result pre="HEV-1 replicated more efficiently at the maternal-fetal interface, produced more" exact="infectious" post="progeny virions, and caused more severe tissue alterations than"/>
 <result pre="genotypes. In addition, genetic HEV variants have shown to affect" exact="viral" post="morphogenesis, pathogenesis, clinical outcomes, and antiviral resistance [121–123]. However,"/>
 <result pre="been linked to morbidity/mortality in pregnancy, and needs further study." exact="Viral" post="proteins The detailed functions of the viral proteins in"/>
 <result pre="needs further study. Viral proteins The detailed functions of the" exact="viral" post="proteins in HEV infection and pathogenesis remain unclear. The"/>
 <result pre="proteins The detailed functions of the viral proteins in HEV" exact="infection" post="and pathogenesis remain unclear. The D29N and V27A mutations"/>
 <result pre="in ORF1-encoded Met were significantly associated with poor outcomes in" exact="acute" post="liver failure patients [124]. V239A mutation in ORF1-encoded Hel"/>
 <result pre="ORF1-encoded Met were significantly associated with poor outcomes in acute" exact="liver failure" post="patients [124]. V239A mutation in ORF1-encoded Hel identified in"/>
 <result pre="patients [124]. V239A mutation in ORF1-encoded Hel identified in severe" exact="hepatitis" post="cases might be associated with increased virulence of the"/>
 <result pre="an imbalance in coagulation and fibrinolysis [131]. Management of HEV" exact="infection" post="during pregnancy Ribavirin was classified in Pregnancy Category X"/>
 <result pre="Management of HEV infection during pregnancy Ribavirin was classified in" exact="Pregnancy" post="Category X by the United States Food and Drug"/>
 <result pre="recommended for use in pregnant women. IFN-α was classified in" exact="Pregnancy" post="Category C by the FDA, taking into account its"/>
 <result pre="studies are needed before sofosbuvir can be recommended for HEV" exact="infection" post="in pregnancy. For the other antiviral candidates mentioned above,"/>
 <result pre="a long way to go. Therefore, the management of HEV" exact="infection" post="in pregnancy is currently supported by diligent monitoring and"/>
 <result pre="Considering that there is no established treatment available for HEV" exact="infection" post="in pregnant women, preventing HEV infection in pregnancy may"/>
 <result pre="treatment available for HEV infection in pregnant women, preventing HEV" exact="infection" post="in pregnancy may be the most important management strategy"/>
 <result pre="adults, three doses of HEV 239 (30 μg of purified recombinant" exact="hepatitis" post="E antigen absorbed to 0.8 mg of aluminium hydroxide suspended"/>
 <result pre="4 not only serve to protect pregnant rabbits from HEV" exact="infection" post="but also prevent HEV-related adverse outcomes [144]. Although the"/>
 <result pre="remain to be determined, this vaccine is promising for HEV" exact="infection" post="prevention in pregnancy and may thus decrease HEV-associated morbidity"/>
 <result pre="in women of childbearing age in rural Bangladesh, where HEV" exact="infection" post="is endemic [145]. Conclusions HEV infection is not limited"/>
 <result pre="rural Bangladesh, where HEV infection is endemic [145]. Conclusions HEV" exact="infection" post="is not limited to certain developing countries; it is"/>
 <result pre="HEV infection is endemic [145]. Conclusions HEV infection is not" exact="limited" post="to certain developing countries; it is also endemic in"/>
 <result pre="nature. Despite increasing knowledge, many questions regarding HEV, especially HEV" exact="infection" post="during pregnancy, remain unanswered. In addition to immune and"/>
 <result pre="HEV variants may be related to the severity of HEV" exact="infection" post="in pregnancy. Therefore, it may be important to investigate"/>
 <result pre="to develop guidelines for the intervention and management of HEV" exact="infection" post="in pregnancy. HEV can be transmitted via blood transfusion."/>
 <result pre="of HEV in voluntary blood donors (VBDs) and transfusion-associated HEV" exact="infections" post="have been reported [1, 4, 10, 146]. Therefore, screening"/>
 <result pre="HEV RNA may need to be considered. Considering that HEV" exact="infection" post="in pregnant women may progress to fulminant hepatitis, especially"/>
 <result pre="with a high mortality rate, screening for and monitoring HEV" exact="infection" post="early in pregnancy should become a focus. In addition,"/>
 <result pre="for novel therapies to treat HEV in pregnancy. Abbreviations HEV" exact="Hepatitis" post="E virus HEV-1 Genotypes 1 HEV-2 Genotypes 2 HEV-3"/>
 <result pre="HEV-3 Genotypes 3 HEV-4 Genotypes 4 IFN-α Interferon-α FHF Fulminant" exact="hepatitis" post="failure eHEV Enveloped HEV UTR Untranslated region ORFs Open"/>
 <result pre="X Macrodomain Hel RNA helicase RdRp RNA-dependent RNA polymerase DIC" exact="Disseminated" post="intravascular coagulation HBV Hepatitis B virus HCV Hepatitis C"/>
 <result pre="helicase RdRp RNA-dependent RNA polymerase DIC Disseminated intravascular coagulation HBV" exact="Hepatitis" post="B virus HCV Hepatitis C virus ALT Alanine aminotransferase"/>
 <result pre="polymerase DIC Disseminated intravascular coagulation HBV Hepatitis B virus HCV" exact="Hepatitis" post="C virus ALT Alanine aminotransferase AST Aspartate aminotransferase HIV"/>
 <result pre="C virus ALT Alanine aminotransferase AST Aspartate aminotransferase HIV Human" exact="immunodeficiency" post="virus NK Natural killer DCs Dendritic cells CMV Cytomegalovirus"/>
 <result pre="virus NK Natural killer DCs Dendritic cells CMV Cytomegalovirus SARS" exact="Severe" post="acute respiratory syndrome HSV Herpes simplex virus AVH Acute"/>
 <result pre="NK Natural killer DCs Dendritic cells CMV Cytomegalovirus SARS Severe" exact="acute" post="respiratory syndrome HSV Herpes simplex virus AVH Acute viral"/>
 <result pre="Natural killer DCs Dendritic cells CMV Cytomegalovirus SARS Severe acute" exact="respiratory" post="syndrome HSV Herpes simplex virus AVH Acute viral hepatitis"/>
 <result pre="killer DCs Dendritic cells CMV Cytomegalovirus SARS Severe acute respiratory" exact="syndrome" post="HSV Herpes simplex virus AVH Acute viral hepatitis HCG"/>
 <result pre="SARS Severe acute respiratory syndrome HSV Herpes simplex virus AVH" exact="Acute" post="viral hepatitis HCG Human chorionic gonadotropin PR Progesterone receptor"/>
 <result pre="Severe acute respiratory syndrome HSV Herpes simplex virus AVH Acute" exact="viral hepatitis" post="HCG Human chorionic gonadotropin PR Progesterone receptor PROGINS Progesterone"/>
 <result pre="acute respiratory syndrome HSV Herpes simplex virus AVH Acute viral" exact="hepatitis" post="HCG Human chorionic gonadotropin PR Progesterone receptor PROGINS Progesterone"/>
 <result pre="PIBF Progesterone-induced blocking factor IRF-3 Interferon regulatory factor 3 MAVS" exact="Mitochondrial" post="antiviral-signaling protein TBK1 TANK-binding kinase 1 FDA Food and"/>
 <result pre="virus: advances and challengesNat Rev Gastroenterol Hepatol2018159611029162935 2.World Health Organization." exact="Hepatitis" post="E. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-e. Accessed 8 July 2019. 3.BazerbachiFHaffarSGargSKLakeJRExtra-hepatic manifestations associated"/>
 <result pre="E. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-e. Accessed 8 July 2019. 3.BazerbachiFHaffarSGargSKLakeJRExtra-hepatic manifestations associated with" exact="hepatitis" post="E virus infection: a comprehensive review of the literatureGastroenterol"/>
 <result pre="control and cureWorld J Gastroenterol2016227030704527610014 5.MengXJZoonotic and foodborne transmission of" exact="hepatitis" post="E virusSemin Liver Dis201333414923564388 6.RivadullaEVarelaMFMesquitaJRNascimentoMSJRomaldeJLDetection of hepatitis E virus"/>
 <result pre="foodborne transmission of hepatitis E virusSemin Liver Dis201333414923564388 6.RivadullaEVarelaMFMesquitaJRNascimentoMSJRomaldeJLDetection of" exact="hepatitis" post="E virus in shellfish harvesting areas from Galicia (northwestern"/>
 <result pre="shellfish harvesting areas from Galicia (northwestern Spain)Viruses2019117618 7.GengYZhaoCGengKWangCWangXLiuHWangYHigh seroprevalence of" exact="hepatitis" post="E virus in rabbit slaughterhouse workersTransbound Emerg Dis2019661085108930661292 8.SaidBIjazSKafatosGBoothLThomasHLWalshARamsayMMorganDHepatitisEIITHepatitis"/>
 <result pre="E outbreak on cruise shipEmerg Infect Dis2009151738174419891860 9.TeiSKitajimaNTakahashiKMishiroSZoonotic transmission of" exact="hepatitis" post="E virus from deer to human beingsLancet200336237137312907011 10.CapaiLCharrelRFalchiAHepatitis E"/>
 <result pre="shift to screening?Euro Surveill201722163051428449730 12.HimmelsbachKBenderDHildtELife cycle and morphogenesis of the" exact="hepatitis" post="E virusEmerg Microbes Infect2018719630498191 13.Kamar N, Abravanel F, Behrendt"/>
 <result pre="L, Horvatits T, De Man RA, et al. Ribavirin for" exact="hepatitis" post="E virus infection after organ transplantation: a large European"/>
 <result pre="T, De Man RA, et al. Ribavirin for hepatitis E" exact="virus infection" post="after organ transplantation: a large European retrospective multicenter study."/>
 <result pre="De Man RA, et al. Ribavirin for hepatitis E virus" exact="infection" post="after organ transplantation: a large European retrospective multicenter study."/>
 <result pre="multicenter study. Clin Infect Dis. 2019. 10.1093/cid/ciz953. 14.KamarNIzopetJTriponSBismuthMHillaireSDumortierJRadenneSCoillyAGarrigueVD'AlterocheLet al.Ribavirin for" exact="chronic hepatitis" post="E virus infection in transplant recipientsN Engl J Med20143701111112024645943"/>
 <result pre="study. Clin Infect Dis. 2019. 10.1093/cid/ciz953. 14.KamarNIzopetJTriponSBismuthMHillaireSDumortierJRadenneSCoillyAGarrigueVD'AlterocheLet al.Ribavirin for chronic" exact="hepatitis" post="E virus infection in transplant recipientsN Engl J Med20143701111112024645943"/>
 <result pre="Infect Dis. 2019. 10.1093/cid/ciz953. 14.KamarNIzopetJTriponSBismuthMHillaireSDumortierJRadenneSCoillyAGarrigueVD'AlterocheLet al.Ribavirin for chronic hepatitis E" exact="virus infection" post="in transplant recipientsN Engl J Med20143701111112024645943 15.ShaoZAl TibiMWakim-FlemingJUpdate on"/>
 <result pre="Dis. 2019. 10.1093/cid/ciz953. 14.KamarNIzopetJTriponSBismuthMHillaireSDumortierJRadenneSCoillyAGarrigueVD'AlterocheLet al.Ribavirin for chronic hepatitis E virus" exact="infection" post="in transplant recipientsN Engl J Med20143701111112024645943 15.ShaoZAl TibiMWakim-FlemingJUpdate on"/>
 <result pre="infection in transplant recipientsN Engl J Med20143701111112024645943 15.ShaoZAl TibiMWakim-FlemingJUpdate on" exact="viral hepatitis" post="in pregnancyCleve Clin J Med20178420220628322675 16.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPet al.Efficacy and safety"/>
 <result pre="in transplant recipientsN Engl J Med20143701111112024645943 15.ShaoZAl TibiMWakim-FlemingJUpdate on viral" exact="hepatitis" post="in pregnancyCleve Clin J Med20178420220628322675 16.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPet al.Efficacy and safety"/>
 <result pre="Clin J Med20178420220628322675 16.ZhuFCZhangJZhangXFZhouCWangZZHuangSJWangHYangCLJiangHMCaiJPet al.Efficacy and safety of a recombinant" exact="hepatitis" post="E vaccine in healthy adults: a large-scale, randomised, double-blind"/>
 <result pre="placebo-controlled, phase 3 trialLancet201037689590220728932 17.KenneySPMengXJTherapeutic targets for the treatment of" exact="hepatitis" post="E virus infectionExpert Opin Ther Targets2015191245126026073772 18.KhurooMSKamiliSAetiology, clinical course"/>
 <result pre="Opin Ther Targets2015191245126026073772 18.KhurooMSKamiliSAetiology, clinical course and outcome of sporadic" exact="acute" post="viral hepatitis in pregnancyJ Viral Hepat200310616912558914 19.Perez-GraciaMTSuay-GarciaBMateos-LindemannMLHepatitis E and"/>
 <result pre="Ther Targets2015191245126026073772 18.KhurooMSKamiliSAetiology, clinical course and outcome of sporadic acute" exact="viral hepatitis" post="in pregnancyJ Viral Hepat200310616912558914 19.Perez-GraciaMTSuay-GarciaBMateos-LindemannMLHepatitis E and pregnancy: current"/>
 <result pre="Targets2015191245126026073772 18.KhurooMSKamiliSAetiology, clinical course and outcome of sporadic acute viral" exact="hepatitis" post="in pregnancyJ Viral Hepat200310616912558914 19.Perez-GraciaMTSuay-GarciaBMateos-LindemannMLHepatitis E and pregnancy: current"/>
 <result pre="course and outcome of sporadic acute viral hepatitis in pregnancyJ" exact="Viral" post="Hepat200310616912558914 19.Perez-GraciaMTSuay-GarciaBMateos-LindemannMLHepatitis E and pregnancy: current stateRev Med Virol2017273e192928318080"/>
 <result pre="Med Virol2017273e192928318080 20.PatraSKumarATrivediSSPuriMSarinSKMaternal and fetal outcomes in pregnant women with" exact="acute hepatitis" post="E virus infectionAnn Intern Med2007147283317606958 21.KhurooMSKhurooMSKhurooNSTransmission of hepatitis E"/>
 <result pre="Virol2017273e192928318080 20.PatraSKumarATrivediSSPuriMSarinSKMaternal and fetal outcomes in pregnant women with acute" exact="hepatitis" post="E virus infectionAnn Intern Med2007147283317606958 21.KhurooMSKhurooMSKhurooNSTransmission of hepatitis E"/>
 <result pre="with acute hepatitis E virus infectionAnn Intern Med2007147283317606958 21.KhurooMSKhurooMSKhurooNSTransmission of" exact="hepatitis" post="E virus in developing countriesViruses201689253 22.KhurooMSKamiliSKhurooMSClinical course and duration"/>
 <result pre="countriesViruses201689253 22.KhurooMSKamiliSKhurooMSClinical course and duration of viremia in vertically transmitted" exact="hepatitis" post="E virus (HEV) infection in babies born to HEV-infected"/>
 <result pre="duration of viremia in vertically transmitted hepatitis E virus (HEV)" exact="infection" post="in babies born to HEV-infected mothersJ Viral Hepat20091651952319228284 23.DebingYNeytsJAntiviral"/>
 <result pre="E virus (HEV) infection in babies born to HEV-infected mothersJ" exact="Viral" post="Hepat20091651952319228284 23.DebingYNeytsJAntiviral strategies for hepatitis E virusAntivir Res201410210611824374149 24.KinastVBurkardTLTodtDSteinmannEHepatitis"/>
 <result pre="babies born to HEV-infected mothersJ Viral Hepat20091651952319228284 23.DebingYNeytsJAntiviral strategies for" exact="hepatitis" post="E virusAntivir Res201410210611824374149 24.KinastVBurkardTLTodtDSteinmannEHepatitis E virus drug developmentViruses2019116485 25.SinclairSMJonesJKMillerRKGreeneMFKwoPYMaddreyWCThe"/>
 <result pre="26.EmersonSUPurcellRHHepatitis E Virus2013PhiladelphiaLippincott Williams &amp;amp; Wilkins 27.KarpeYALoleKSDeubiquitination activity associated with" exact="hepatitis" post="E virus putative papain-like cysteine proteaseJ Gen Virol2011922088209221653754 28.LhommeSAbravanelFDuboisMSandres-SauneKMansuyJMRostaingLKamarNIzopetJCharacterization"/>
 <result pre="proteaseJ Gen Virol2011922088209221653754 28.LhommeSAbravanelFDuboisMSandres-SauneKMansuyJMRostaingLKamarNIzopetJCharacterization of the polyproline region of the" exact="hepatitis" post="E virus in immunocompromised patientsJ Virol201488120171202525100839 29.KarpeYALoleKSRNA 5′-triphosphatase activity"/>
 <result pre="virus in immunocompromised patientsJ Virol201488120171202525100839 29.KarpeYALoleKSRNA 5′-triphosphatase activity of the" exact="hepatitis" post="E virus helicase domainJ Virol2010849637964120592074 30.KarpeYALoleKSNTPase and 5′ to"/>
 <result pre="30.KarpeYALoleKSNTPase and 5′ to 3′ RNA duplex-unwinding activities of the" exact="hepatitis" post="E virus helicase domainJ Virol2010843595360220071563 31.AgrawalSGuptaDPandaSKThe 3′ end of"/>
 <result pre="hepatitis E virus helicase domainJ Virol2010843595360220071563 31.AgrawalSGuptaDPandaSKThe 3′ end of" exact="hepatitis" post="E virus (HEV) genome binds specifically to the viral"/>
 <result pre="of hepatitis E virus (HEV) genome binds specifically to the" exact="viral" post="RNA-dependent RNA polymerase (RdRp)Virology20012828710111259193 32.RehmanSKapurNDurgapalHPandaSKSubcellular localization of hepatitis E"/>
 <result pre="to the viral RNA-dependent RNA polymerase (RdRp)Virology20012828710111259193 32.RehmanSKapurNDurgapalHPandaSKSubcellular localization of" exact="hepatitis" post="E virus (HEV) replicaseVirology2008370779217904184 33.KooninEVGorbalenyaAEPurdyMARozanovMNReyesGRBradleyDWComputer-assisted assignment of functional domains"/>
 <result pre="33.KooninEVGorbalenyaAEPurdyMARozanovMNReyesGRBradleyDWComputer-assisted assignment of functional domains in the nonstructural polyprotein of" exact="hepatitis" post="E virus: delineation of an additional group of positive-strand"/>
 <result pre="subgenomic mRNA encodes both the ORF2 and ORF3 proteins of" exact="hepatitis" post="E virusJ Virol2006805919592616731930 35.YinXYingDLhommeSTangZWalkerCMXiaNZhengZFengZOrigin, antigenicity, and function of a"/>
 <result pre="antigenicity, and function of a secreted form of ORF2 in" exact="hepatitis" post="E virus infectionProc Natl Acad Sci U S A20181154773477829669922"/>
 <result pre="of the ORF2 capsid proteinGastroenterology2018154211223.e21828958858 37.CaoDMengXJMolecular biology and replication of" exact="hepatitis" post="E virusEmerg Microbes Infect20121e1726038426 38.YinXAmbardekarCLuYFengZDistinct entry mechanisms for nonenveloped"/>
 <result pre="virusEmerg Microbes Infect20121e1726038426 38.YinXAmbardekarCLuYFengZDistinct entry mechanisms for nonenveloped and quasi-enveloped" exact="hepatitis" post="E virusesJ Virol2016904232424226865708 39.PerttilaJSpuulPAholaTEarly secretory pathway localization and lack"/>
 <result pre="Virol2016904232424226865708 39.PerttilaJSpuulPAholaTEarly secretory pathway localization and lack of processing for" exact="hepatitis" post="E virus replication protein pORF1J Gen Virol20139480781623255617 40.GraffJNguyenHKasorndorkbuaCHalburPGSt ClaireMPurcellRHEmersonSUIn"/>
 <result pre="and in vivo mutational analysis of the 3′-terminal regions of" exact="hepatitis" post="e virus genomes and repliconsJ Virol2005791017102615613330 41.SurjitMJameelSLalSKThe ORF2 protein"/>
 <result pre="e virus genomes and repliconsJ Virol2005791017102615613330 41.SurjitMJameelSLalSKThe ORF2 protein of" exact="hepatitis" post="E virus binds the 5′ region of viral RNAJ"/>
 <result pre="protein of hepatitis E virus binds the 5′ region of" exact="viral" post="RNAJ Virol20047832032814671114 42.KarPSenguptaAA guide to the management of hepatitis"/>
 <result pre="of viral RNAJ Virol20047832032814671114 42.KarPSenguptaAA guide to the management of" exact="hepatitis" post="E infection during pregnancyExpert Rev Gastroenterol Hepatol20191320521130791760 43.KhurooMSTeliMRSkidmoreSSofiMAKhurooMIIncidence and"/>
 <result pre="RNAJ Virol20047832032814671114 42.KarPSenguptaAA guide to the management of hepatitis E" exact="infection" post="during pregnancyExpert Rev Gastroenterol Hepatol20191320521130791760 43.KhurooMSTeliMRSkidmoreSSofiMAKhurooMIIncidence and severity of"/>
 <result pre="infection during pregnancyExpert Rev Gastroenterol Hepatol20191320521130791760 43.KhurooMSTeliMRSkidmoreSSofiMAKhurooMIIncidence and severity of" exact="viral hepatitis" post="in pregnancyAm J Med1981702522556781338 44.JaiswalSPJainAKNaikGSoniNChitnisDSViral hepatitis during pregnancyInt J"/>
 <result pre="during pregnancyExpert Rev Gastroenterol Hepatol20191320521130791760 43.KhurooMSTeliMRSkidmoreSSofiMAKhurooMIIncidence and severity of viral" exact="hepatitis" post="in pregnancyAm J Med1981702522556781338 44.JaiswalSPJainAKNaikGSoniNChitnisDSViral hepatitis during pregnancyInt J"/>
 <result pre="and severity of viral hepatitis in pregnancyAm J Med1981702522556781338 44.JaiswalSPJainAKNaikGSoniNChitnisDSViral" exact="hepatitis" post="during pregnancyInt J Gynaecol Obstet20017210310811166742 45.AzizABHamidSIqbalSIslamWKarimSAPrevalence and severity of"/>
 <result pre="hepatitis during pregnancyInt J Gynaecol Obstet20017210310811166742 45.AzizABHamidSIqbalSIslamWKarimSAPrevalence and severity of" exact="viral hepatitis" post="in Pakistani pregnant women: a five year hospital based"/>
 <result pre="during pregnancyInt J Gynaecol Obstet20017210310811166742 45.AzizABHamidSIqbalSIslamWKarimSAPrevalence and severity of viral" exact="hepatitis" post="in Pakistani pregnant women: a five year hospital based"/>
 <result pre="a five year hospital based studyJ Pak Med Assoc1997471982019339616 46.DahiyaMKumarAKarPGuptaRKKumarAAcute" exact="viral hepatitis" post="in third trimester of pregnancyIndian J Gastroenterol20052412812916041115 47.ShresthaPBhandariDSharmaDBhandariBPA study"/>
 <result pre="five year hospital based studyJ Pak Med Assoc1997471982019339616 46.DahiyaMKumarAKarPGuptaRKKumarAAcute viral" exact="hepatitis" post="in third trimester of pregnancyIndian J Gastroenterol20052412812916041115 47.ShresthaPBhandariDSharmaDBhandariBPA study"/>
 <result pre="in third trimester of pregnancyIndian J Gastroenterol20052412812916041115 47.ShresthaPBhandariDSharmaDBhandariBPA study of" exact="viral hepatitis" post="during pregnancy in Nepal medical college teaching hospitalNepal Med"/>
 <result pre="third trimester of pregnancyIndian J Gastroenterol20052412812916041115 47.ShresthaPBhandariDSharmaDBhandariBPA study of viral" exact="hepatitis" post="during pregnancy in Nepal medical college teaching hospitalNepal Med"/>
 <result pre="medical college teaching hospitalNepal Med Coll J20091119219420334069 48.KhurooMSKamiliSJameelSVertical transmission of" exact="hepatitis" post="E virusLancet1995345102510267723501 49.LachishTErezODaudiNShouvalDSchwartzEAcute hepatitis E virus in pregnant women"/>
 <result pre="Med Coll J20091119219420334069 48.KhurooMSKamiliSJameelSVertical transmission of hepatitis E virusLancet1995345102510267723501 49.LachishTErezODaudiNShouvalDSchwartzEAcute" exact="hepatitis" post="E virus in pregnant women in Israel and in"/>
 <result pre="other industrialized countriesJ Clin Virol201573202426521225 50.AntyROllierLPeronJMNicandECannavoIBongainAGiordanengoVTranAFirst case report of an" exact="acute" post="genotype 3 hepatitis E infected pregnant woman living in"/>
 <result pre="Clin Virol201573202426521225 50.AntyROllierLPeronJMNicandECannavoIBongainAGiordanengoVTranAFirst case report of an acute genotype 3" exact="hepatitis" post="E infected pregnant woman living in south-eastern FranceJ Clin"/>
 <result pre="in south-eastern FranceJ Clin Virol201254767822336086 51.TabatabaiJWenzelJJSoboletzkiMFluxCNavidMHSchnitzlerPFirst case report of an" exact="acute hepatitis" post="E subgenotype 3c infection during pregnancy in GermanyJ Clin"/>
 <result pre="south-eastern FranceJ Clin Virol201254767822336086 51.TabatabaiJWenzelJJSoboletzkiMFluxCNavidMHSchnitzlerPFirst case report of an acute" exact="hepatitis" post="E subgenotype 3c infection during pregnancy in GermanyJ Clin"/>
 <result pre="51.TabatabaiJWenzelJJSoboletzkiMFluxCNavidMHSchnitzlerPFirst case report of an acute hepatitis E subgenotype 3c" exact="infection" post="during pregnancy in GermanyJ Clin Virol20146117017224996764 52.LiRCGeSXLiYPZhengYJNongYGuoQSZhangJNgMHXiaNSSeroprevalence of hepatitis"/>
 <result pre="3c infection during pregnancy in GermanyJ Clin Virol20146117017224996764 52.LiRCGeSXLiYPZhengYJNongYGuoQSZhangJNgMHXiaNSSeroprevalence of" exact="hepatitis" post="E virus infection, rural southern People's Republic of ChinaEmerg"/>
 <result pre="during pregnancy in GermanyJ Clin Virol20146117017224996764 52.LiRCGeSXLiYPZhengYJNongYGuoQSZhangJNgMHXiaNSSeroprevalence of hepatitis E" exact="virus infection," post="rural southern People's Republic of ChinaEmerg Infect Dis2006121682168817283617 53.TangWFKongDGWangYHLiuMQHuQHepatitis"/>
 <result pre="rural southern People's Republic of ChinaEmerg Infect Dis2006121682168817283617 53.TangWFKongDGWangYHLiuMQHuQHepatitis E" exact="virus infection" post="in Wuhan, Central ChinaArch Virol2019164273230229302 54.CongWSuiJCZhangXYQianADChenJZhuXQSeroprevalence of hepatitis E"/>
 <result pre="southern People's Republic of ChinaEmerg Infect Dis2006121682168817283617 53.TangWFKongDGWangYHLiuMQHuQHepatitis E virus" exact="infection" post="in Wuhan, Central ChinaArch Virol2019164273230229302 54.CongWSuiJCZhangXYQianADChenJZhuXQSeroprevalence of hepatitis E"/>
 <result pre="of ChinaEmerg Infect Dis2006121682168817283617 53.TangWFKongDGWangYHLiuMQHuQHepatitis E virus infection in Wuhan," exact="Central" post="ChinaArch Virol2019164273230229302 54.CongWSuiJCZhangXYQianADChenJZhuXQSeroprevalence of hepatitis E virus among pregnant"/>
 <result pre="E virus infection in Wuhan, Central ChinaArch Virol2019164273230229302 54.CongWSuiJCZhangXYQianADChenJZhuXQSeroprevalence of" exact="hepatitis" post="E virus among pregnant women and control subjects in"/>
 <result pre="E virus seroprevalence in pregnant women in Jiangsu, China, and" exact="postpartum" post="evolution during six yearsBMC Infect Dis20151556026653888 56.HuangFMaTLiLZengWJingSLow seroprevalence of"/>
 <result pre="postpartum evolution during six yearsBMC Infect Dis20151556026653888 56.HuangFMaTLiLZengWJingSLow seroprevalence of" exact="hepatitis" post="E virus infection in pregnant women in Yunnan, ChinaBraz"/>
 <result pre="during six yearsBMC Infect Dis20151556026653888 56.HuangFMaTLiLZengWJingSLow seroprevalence of hepatitis E" exact="virus infection" post="in pregnant women in Yunnan, ChinaBraz J Infect Dis20131771671724055390"/>
 <result pre="six yearsBMC Infect Dis20151556026653888 56.HuangFMaTLiLZengWJingSLow seroprevalence of hepatitis E virus" exact="infection" post="in pregnant women in Yunnan, ChinaBraz J Infect Dis20131771671724055390"/>
 <result pre="Infect Dis20131771671724055390 57.DrobeniucJMengJReuterGGreene-MontfortTKhudyakovaNDimitrovaZKamiliSTeoCGSerologic assays specific to immunoglobulin M antibodies against" exact="hepatitis" post="E virus: pangenotypic evaluation of performancesClin Infect Dis201051e24e2720578874 58.KhudyakovYKamiliSSerological"/>
 <result pre="virus: pangenotypic evaluation of performancesClin Infect Dis201051e24e2720578874 58.KhudyakovYKamiliSSerological diagnostics of" exact="hepatitis" post="E virus infectionVirus Res2011161849221704091 59.ArendsJEGhisettiVIrvingWDaltonHRIzopetJHoepelmanAISalmonDHepatitis E: an emerging infection"/>
 <result pre="of hepatitis E virus infectionVirus Res2011161849221704091 59.ArendsJEGhisettiVIrvingWDaltonHRIzopetJHoepelmanAISalmonDHepatitis E: an emerging" exact="infection" post="in high income countriesJ Clin Virol201459818824388207 60.Al-SadeqDWMajdalawiehAFMeslehAGAbdallaOMNasrallahGKLaboratory challenges in"/>
 <result pre="income countriesJ Clin Virol201459818824388207 60.Al-SadeqDWMajdalawiehAFMeslehAGAbdallaOMNasrallahGKLaboratory challenges in the diagnosis of" exact="hepatitis" post="E virusJ Med Microbiol20186746648029485390 61.Li M, Bu Q, Gong"/>
 <result pre="L, Li S, Sridhar S, Cy Woo P, Wang L." exact="Hepatitis" post="E virus infection and its associated adverse feto-maternal outcomes"/>
 <result pre="S, Sridhar S, Cy Woo P, Wang L. Hepatitis E" exact="virus infection" post="and its associated adverse feto-maternal outcomes among pregnant women"/>
 <result pre="Sridhar S, Cy Woo P, Wang L. Hepatitis E virus" exact="infection" post="and its associated adverse feto-maternal outcomes among pregnant women"/>
 <result pre="outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal" exact="Neonatal" post="Med. 2019:1–5. 10.1080/14767058.2019.1582630. 62.BouquetJChevalJRogeeSPavioNEloitMIdentical consensus sequence and conserved genomic"/>
 <result pre="2019:1–5. 10.1080/14767058.2019.1582630. 62.BouquetJChevalJRogeeSPavioNEloitMIdentical consensus sequence and conserved genomic polymorphism of" exact="hepatitis" post="E virus during controlled interspecies transmissionJ Virol2012866238624522457521 63.AyeTTUchidaTMaXZIidaFShikataTZhuangHWinKMComplete nucleotide"/>
 <result pre="during controlled interspecies transmissionJ Virol2012866238624522457521 63.AyeTTUchidaTMaXZIidaFShikataTZhuangHWinKMComplete nucleotide sequence of a" exact="hepatitis" post="E virus isolated from the Xinjiang epidemic (1986-1988) of"/>
 <result pre="from the Xinjiang epidemic (1986-1988) of ChinaNucleic Acids Res19922035121630924 64.AslamASusheelaAIrianaSChanSSLauDAcute" exact="hepatitis" post="E superinfection leading to chronic hepatitis B reactivationBMJ Case"/>
 <result pre="of ChinaNucleic Acids Res19922035121630924 64.AslamASusheelaAIrianaSChanSSLauDAcute hepatitis E superinfection leading to" exact="chronic hepatitis" post="B reactivationBMJ Case Rep20182018bcr2017223616 65.Blasco-PerrinHMaddenRGStanleyACrossanCHunterJGVineLLaneKDevooght-JohnsonNMcLaughlinCPetrikJet al.Hepatitis E virus in"/>
 <result pre="ChinaNucleic Acids Res19922035121630924 64.AslamASusheelaAIrianaSChanSSLauDAcute hepatitis E superinfection leading to chronic" exact="hepatitis" post="B reactivationBMJ Case Rep20182018bcr2017223616 65.Blasco-PerrinHMaddenRGStanleyACrossanCHunterJGVineLLaneKDevooght-JohnsonNMcLaughlinCPetrikJet al.Hepatitis E virus in"/>
 <result pre="Case Rep20182018bcr2017223616 65.Blasco-PerrinHMaddenRGStanleyACrossanCHunterJGVineLLaneKDevooght-JohnsonNMcLaughlinCPetrikJet al.Hepatitis E virus in patients with decompensated" exact="chronic" post="liver disease: a prospective UK/French studyAliment Pharmacol Ther20154257458126174470 66.GadYZMousaNShamsMElewaASeroprevalence"/>
 <result pre="a prospective UK/French studyAliment Pharmacol Ther20154257458126174470 66.GadYZMousaNShamsMElewaASeroprevalence of subclinical HEV" exact="infection" post="in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate,"/>
 <result pre="pregnant women in Dakahlya Governorate, EgyptAsian J Transfus Sci2011513613921897591 67.SayedIMVercouterASAbdelwahabSFVercauterenKMeulemanPIs" exact="hepatitis" post="E virus an emerging problem in industrialized countries?Hepatology2015621883189226175182 68.ChauTNLaiSTTseCNgTKLeungVKLimWNgMHEpidemiology"/>
 <result pre="problem in industrialized countries?Hepatology2015621883189226175182 68.ChauTNLaiSTTseCNgTKLeungVKLimWNgMHEpidemiology and clinical features of sporadic" exact="hepatitis" post="E as compared with hepatitis AAm J Gastroenterol200610129229616454833 69.MansuyJMAbravanelFMiedougeMMengelleCMervielCDuboisMKamarNRostaingLAlricLMoreauJet"/>
 <result pre="and clinical features of sporadic hepatitis E as compared with" exact="hepatitis" post="AAm J Gastroenterol200610129229616454833 69.MansuyJMAbravanelFMiedougeMMengelleCMervielCDuboisMKamarNRostaingLAlricLMoreauJet al.Acute hepatitis E in south-west"/>
 <result pre="E as compared with hepatitis AAm J Gastroenterol200610129229616454833 69.MansuyJMAbravanelFMiedougeMMengelleCMervielCDuboisMKamarNRostaingLAlricLMoreauJet al.Acute" exact="hepatitis" post="E in south-west France over a 5-year periodJ Clin"/>
 <result pre="over a 5-year periodJ Clin Virol200944747718993112 70.WedemeyerHPischkeSMannsMPPathogenesis and treatment of" exact="hepatitis" post="e virus infectionGastroenterology201214213881397.e138122537448 71.DonnellyMCScobieLCrossanCLDaltonHHayesPCSimpsonKJReview article: hepatitis E-a concise review"/>
 <result pre="70.WedemeyerHPischkeSMannsMPPathogenesis and treatment of hepatitis e virus infectionGastroenterology201214213881397.e138122537448 71.DonnellyMCScobieLCrossanCLDaltonHHayesPCSimpsonKJReview article:" exact="hepatitis" post="E-a concise review of virology, epidemiology, clinical presentation and"/>
 <result pre="epidemiology, clinical presentation and therapyAliment Pharmacol Ther20174612614128449246 72.RayisDAJumaaAMGasimGIKarsanyMSAdamIAn outbreak of" exact="hepatitis" post="E and high maternal mortality at Port Sudan, eastern"/>
 <result pre="maternal mortality at Port Sudan, eastern SudanPathog Glob Health2013107666823683332 73.KhaskheliMNBalochSSheebaABalochSAcute" exact="hepatitis" post="E viral infection in pregnancy and maternal morbidityJ Coll"/>
 <result pre="at Port Sudan, eastern SudanPathog Glob Health2013107666823683332 73.KhaskheliMNBalochSSheebaABalochSAcute hepatitis E" exact="viral infection" post="in pregnancy and maternal morbidityJ Coll Physicians Surg Pak20152573473726454389"/>
 <result pre="Port Sudan, eastern SudanPathog Glob Health2013107666823683332 73.KhaskheliMNBalochSSheebaABalochSAcute hepatitis E viral" exact="infection" post="in pregnancy and maternal morbidityJ Coll Physicians Surg Pak20152573473726454389"/>
 <result pre="pregnancy and maternal morbidityJ Coll Physicians Surg Pak20152573473726454389 74.KamarNRostaingLLegrand-AbravanelFIzopetJHow should" exact="hepatitis" post="E virus infection be defined in organ-transplant recipients?Am J"/>
 <result pre="maternal morbidityJ Coll Physicians Surg Pak20152573473726454389 74.KamarNRostaingLLegrand-AbravanelFIzopetJHow should hepatitis E" exact="virus infection" post="be defined in organ-transplant recipients?Am J Transplant2013131935193623659713 75.GerolamiRMoalVColsonPChronic hepatitis"/>
 <result pre="morbidityJ Coll Physicians Surg Pak20152573473726454389 74.KamarNRostaingLLegrand-AbravanelFIzopetJHow should hepatitis E virus" exact="infection" post="be defined in organ-transplant recipients?Am J Transplant2013131935193623659713 75.GerolamiRMoalVColsonPChronic hepatitis"/>
 <result pre="virus infection be defined in organ-transplant recipients?Am J Transplant2013131935193623659713 75.GerolamiRMoalVColsonPChronic" exact="hepatitis" post="E with cirrhosis in a kidney-transplant recipientN Engl J"/>
 <result pre="defined in organ-transplant recipients?Am J Transplant2013131935193623659713 75.GerolamiRMoalVColsonPChronic hepatitis E with" exact="cirrhosis" post="in a kidney-transplant recipientN Engl J Med200835885986018287615 76.de NietAZaaijerHLten"/>
 <result pre="in a kidney-transplant recipientN Engl J Med200835885986018287615 76.de NietAZaaijerHLten BergeIWeeginkCJReesinkHWBeuersUChronic" exact="hepatitis" post="E after solid organ transplantationNeth J Med20127026126622859417 77.HaagsmaEBvan den"/>
 <result pre="E after solid organ transplantationNeth J Med20127026126622859417 77.HaagsmaEBvan den BergAPPorteRJBenneCAVennemaHReimerinkJHKoopmansMPChronic" exact="hepatitis" post="E virus infection in liver transplant recipientsLiver Transpl20081454755318383084 78.RenouCLafeuilladeACadranelJFPavioNParienteAAllegreTPoggiCPenarandaGCordierFNicandEHepatitis"/>
 <result pre="solid organ transplantationNeth J Med20127026126622859417 77.HaagsmaEBvan den BergAPPorteRJBenneCAVennemaHReimerinkJHKoopmansMPChronic hepatitis E" exact="virus infection" post="in liver transplant recipientsLiver Transpl20081454755318383084 78.RenouCLafeuilladeACadranelJFPavioNParienteAAllegreTPoggiCPenarandaGCordierFNicandEHepatitis E virus in"/>
 <result pre="organ transplantationNeth J Med20127026126622859417 77.HaagsmaEBvan den BergAPPorteRJBenneCAVennemaHReimerinkJHKoopmansMPChronic hepatitis E virus" exact="infection" post="in liver transplant recipientsLiver Transpl20081454755318383084 78.RenouCLafeuilladeACadranelJFPavioNParienteAAllegreTPoggiCPenarandaGCordierFNicandEHepatitis E virus in"/>
 <result pre="Transpl20081454755318383084 78.RenouCLafeuilladeACadranelJFPavioNParienteAAllegreTPoggiCPenarandaGCordierFNicandEHepatitis E virus in HIV-infected patientsAIDS2010241493149920467291 79.DaltonHRBendallRPKeaneFETedderRSIjazSPersistent carriage of" exact="hepatitis" post="E virus in patients with HIV infectionN Engl J"/>
 <result pre="virus in patients with HIV infectionN Engl J Med20093611025102719726781 80.GengYZhangHHuangWHarrisonTJGengKLiZWangYPersistent" exact="hepatitis" post="e virus genotype 4 infection in a child with"/>
 <result pre="infectionN Engl J Med20093611025102719726781 80.GengYZhangHHuangWHarrisonTJGengKLiZWangYPersistent hepatitis e virus genotype 4" exact="infection" post="in a child with acute lymphoblastic leukemiaHepat Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic"/>
 <result pre="hepatitis e virus genotype 4 infection in a child with" exact="acute" post="lymphoblastic leukemiaHepat Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic hepatitis E virus infection in"/>
 <result pre="infection in a child with acute lymphoblastic leukemiaHepat Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic" exact="hepatitis" post="E virus infection in a patient with leukemia and"/>
 <result pre="a child with acute lymphoblastic leukemiaHepat Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic hepatitis E" exact="virus infection" post="in a patient with leukemia and elevated transaminases: a"/>
 <result pre="child with acute lymphoblastic leukemiaHepat Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic hepatitis E virus" exact="infection" post="in a patient with leukemia and elevated transaminases: a"/>
 <result pre="Mon201414e1561824596581 81.GaussAWenzelJJFlechtenmacherCNavidMHEisenbachCJilgWStremmelWSchnitzlerPChronic hepatitis E virus infection in a patient with" exact="leukemia" post="and elevated transaminases: a case reportJ Med Case Rep2012633423031738"/>
 <result pre="with hematological malignanciesJ Clin Virol20104914114420678959 83.KamarNSelvesJMansuyJMOuezzaniLPeronJMGuitardJCointaultOEspositoLAbravanelFDanjouxMet al.Hepatitis E virus and" exact="chronic hepatitis" post="in organ-transplant recipientsN Engl J Med200835881181718287603 84.LhommeSMarionOAbravanelFIzopetJKamarNClinical manifestations, pathogenesis"/>
 <result pre="hematological malignanciesJ Clin Virol20104914114420678959 83.KamarNSelvesJMansuyJMOuezzaniLPeronJMGuitardJCointaultOEspositoLAbravanelFDanjouxMet al.Hepatitis E virus and chronic" exact="hepatitis" post="in organ-transplant recipientsN Engl J Med200835881181718287603 84.LhommeSMarionOAbravanelFIzopetJKamarNClinical manifestations, pathogenesis"/>
 <result pre="recipientsN Engl J Med200835881181718287603 84.LhommeSMarionOAbravanelFIzopetJKamarNClinical manifestations, pathogenesis and treatment of" exact="hepatitis" post="E virus infectionsJ Clin Med202092331 85.KamarNMansuyJMCointaultOSelvesJAbravanelFDanjouxMOtalPEspositoLDurandDIzopetJRostaingLHepatitis E virus-related cirrhosis"/>
 <result pre="of hepatitis E virus infectionsJ Clin Med202092331 85.KamarNMansuyJMCointaultOSelvesJAbravanelFDanjouxMOtalPEspositoLDurandDIzopetJRostaingLHepatitis E virus-related" exact="cirrhosis" post="in kidney- and kidney-pancreas-transplant recipientsAm J Transplant200881744174818557740 86.LhommeSMarionOAbravanelFChapuy-RegaudSKamarNIzopetJHepatitis E"/>
 <result pre="J Transplant200881744174818557740 86.LhommeSMarionOAbravanelFChapuy-RegaudSKamarNIzopetJHepatitis E pathogenesisViruses201688212 87.PischkeSHartlJPasSDLohseAWJacobsBCVan der EijkAAHepatitis E virus:" exact="infection" post="beyond the liver?J Hepatol2017661082109527913223 88.KamarNIzopetJPavioNAggarwalRLabriqueAWedemeyerHDaltonHRHepatitis E virus infectionNat Rev"/>
 <result pre="liver?J Hepatol2017661082109527913223 88.KamarNIzopetJPavioNAggarwalRLabriqueAWedemeyerHDaltonHRHepatitis E virus infectionNat Rev Dis Primers201731708629154369 89.DumoulinFLLieseHAcute" exact="hepatitis" post="E virus infection and autoimmune thyroiditis: yet another trigger?BMJ"/>
 <result pre="88.KamarNIzopetJPavioNAggarwalRLabriqueAWedemeyerHDaltonHRHepatitis E virus infectionNat Rev Dis Primers201731708629154369 89.DumoulinFLLieseHAcute hepatitis E" exact="virus infection" post="and autoimmune thyroiditis: yet another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere"/>
 <result pre="E virus infectionNat Rev Dis Primers201731708629154369 89.DumoulinFLLieseHAcute hepatitis E virus" exact="infection" post="and autoimmune thyroiditis: yet another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere"/>
 <result pre="infectionNat Rev Dis Primers201731708629154369 89.DumoulinFLLieseHAcute hepatitis E virus infection and" exact="autoimmune" post="thyroiditis: yet another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere thrombocytopenia associated"/>
 <result pre="infection and autoimmune thyroiditis: yet another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere" exact="thrombocytopenia" post="associated with acute autochthonous hepatitis EJ Clin Virol201048737420308017 91.DenielCCotonTBrardjanianSGuissetMNicandESimonFAcute"/>
 <result pre="thyroiditis: yet another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere thrombocytopenia associated with" exact="acute" post="autochthonous hepatitis EJ Clin Virol201048737420308017 91.DenielCCotonTBrardjanianSGuissetMNicandESimonFAcute pancreatitis: a rare"/>
 <result pre="another trigger?BMJ Case Rep20122012bcr122011544122604767 90.FourquetEMansuyJMBureauCRecherCVinelJPIzopetJPeronJMSevere thrombocytopenia associated with acute autochthonous" exact="hepatitis" post="EJ Clin Virol201048737420308017 91.DenielCCotonTBrardjanianSGuissetMNicandESimonFAcute pancreatitis: a rare complication of"/>
 <result pre="hepatitis EJ Clin Virol201048737420308017 91.DenielCCotonTBrardjanianSGuissetMNicandESimonFAcute pancreatitis: a rare complication of" exact="acute hepatitis" post="EJ Clin Virol20115120220421628104 92.Munoz-SuanoAHamiltonABBetzAGGimme shelter: the immune system during"/>
 <result pre="EJ Clin Virol201048737420308017 91.DenielCCotonTBrardjanianSGuissetMNicandESimonFAcute pancreatitis: a rare complication of acute" exact="hepatitis" post="EJ Clin Virol20115120220421628104 92.Munoz-SuanoAHamiltonABBetzAGGimme shelter: the immune system during"/>
 <result pre="pregnancyImmunol Rev2011241203821488887 93.KrausTAEngelSMSperlingRSKellermanLLoYWallensteinSEscribeseMMGarridoJLSinghTLoubeauMMoranTMCharacterizing the pregnancy immune phenotype: results of the" exact="viral" post="immunity and pregnancy (VIP) studyJ Clin Immunol20123230031122198680 94.PazosMSperlingRSMoranTMKrausTAThe influence"/>
 <result pre="pregnancy (VIP) studyJ Clin Immunol20123230031122198680 94.PazosMSperlingRSMoranTMKrausTAThe influence of pregnancy on" exact="systemic" post="immunityImmunol Res20125425426122447351 95.ZollerALSchnellFJKershGJMurine pregnancy leads to reduced proliferation of"/>
 <result pre="thymic emigrationImmunology200712120721517250584 96.KourtisAPReadJSJamiesonDJPregnancy and infectionN Engl J Med20143702211221824897084 97.SappenfieldEJamiesonDJKourtisAPPregnancy and" exact="susceptibility to" post="infectious diseasesInfect Dis Obstet Gynecol2013201375285223935259 98.SaitoSNakashimaAShimaTItoMTh1/Th2/Th17 and regulatory T-cell"/>
 <result pre="96.KourtisAPReadJSJamiesonDJPregnancy and infectionN Engl J Med20143702211221824897084 97.SappenfieldEJamiesonDJKourtisAPPregnancy and susceptibility to" exact="infectious" post="diseasesInfect Dis Obstet Gynecol2013201375285223935259 98.SaitoSNakashimaAShimaTItoMTh1/Th2/Th17 and regulatory T-cell paradigm"/>
 <result pre="self and non-selfNat Immunol2005634535215785760 101.PalRAggarwalRNaikSRDasVDasSNaikSImmunological alterations in pregnant women with" exact="acute hepatitis" post="EJ Gastroenterol Hepatol2005201094110115955220 102.WedemeyerHRybczynskaJPischkeSKrawczynskiKImmunopathogenesis of hepatitis E virus infectionSemin"/>
 <result pre="and non-selfNat Immunol2005634535215785760 101.PalRAggarwalRNaikSRDasVDasSNaikSImmunological alterations in pregnant women with acute" exact="hepatitis" post="EJ Gastroenterol Hepatol2005201094110115955220 102.WedemeyerHRybczynskaJPischkeSKrawczynskiKImmunopathogenesis of hepatitis E virus infectionSemin"/>
 <result pre="pregnant women with acute hepatitis EJ Gastroenterol Hepatol2005201094110115955220 102.WedemeyerHRybczynskaJPischkeSKrawczynskiKImmunopathogenesis of" exact="hepatitis" post="E virus infectionSemin Liver Dis201333717823564391 103.GuidottiLGChisariFVNoncytolytic control of viral"/>
 <result pre="of hepatitis E virus infectionSemin Liver Dis201333717823564391 103.GuidottiLGChisariFVNoncytolytic control of" exact="viral" post="infections by the innate and adaptive immune responseAnnu Rev"/>
 <result pre="hepatitis E virus infectionSemin Liver Dis201333717823564391 103.GuidottiLGChisariFVNoncytolytic control of viral" exact="infections" post="by the innate and adaptive immune responseAnnu Rev Immunol200119659111244031"/>
 <result pre="the innate and adaptive immune responseAnnu Rev Immunol200119659111244031 104.JilaniNDasBCHusainSABawejaUKChattopadhyaDGuptaRKSardanaSKarPHepatitis E" exact="virus infection" post="and fulminant hepatic failure during pregnancyJ Gastroenterol Hepatol20072267668217444855 105.SehgalRPatraSDavidPVyasAKhanamAHissarSGuptaEKumarGKottililSMaiwallRet"/>
 <result pre="innate and adaptive immune responseAnnu Rev Immunol200119659111244031 104.JilaniNDasBCHusainSABawejaUKChattopadhyaDGuptaRKSardanaSKarPHepatitis E virus" exact="infection" post="and fulminant hepatic failure during pregnancyJ Gastroenterol Hepatol20072267668217444855 105.SehgalRPatraSDavidPVyasAKhanamAHissarSGuptaEKumarGKottililSMaiwallRet"/>
 <result pre="105.SehgalRPatraSDavidPVyasAKhanamAHissarSGuptaEKumarGKottililSMaiwallRet al.Impaired monocyte-macrophage functions and defective toll-like receptor signaling in" exact="hepatitis" post="E virus-infected pregnant women with acute liver failureHepatology2015621683169626331854 106.PrustyBKHedauSSinghAKarPDasBCSelective"/>
 <result pre="toll-like receptor signaling in hepatitis E virus-infected pregnant women with" exact="acute" post="liver failureHepatology2015621683169626331854 106.PrustyBKHedauSSinghAKarPDasBCSelective suppression of NF-kBp65 in hepatitis virus-infected"/>
 <result pre="women with acute liver failureHepatology2015621683169626331854 106.PrustyBKHedauSSinghAKarPDasBCSelective suppression of NF-kBp65 in" exact="hepatitis" post="virus-infected pregnant women manifesting severe liver damage and high"/>
 <result pre="liver damage and high mortalityMol Med20071351852617660862 107.KumarADeviSGKarPAgarwalSHusainSAGuptaRKSharmaSAssociation of cytokines in" exact="hepatitis" post="E with pregnancy outcomeCytokine2014659510424416783 108.KmushBLLabriqueALiWKleinSLSchulzeKShaikhSAliHEngleREWuLPurcellRHet al.The association of cytokines"/>
 <result pre="pregnancy outcomeCytokine2014659510424416783 108.KmushBLLabriqueALiWKleinSLSchulzeKShaikhSAliHEngleREWuLPurcellRHet al.The association of cytokines and micronutrients with" exact="hepatitis" post="E virus infection during pregnancy and the postpartum period"/>
 <result pre="108.KmushBLLabriqueALiWKleinSLSchulzeKShaikhSAliHEngleREWuLPurcellRHet al.The association of cytokines and micronutrients with hepatitis E" exact="virus infection" post="during pregnancy and the postpartum period in rural BangladeshAm"/>
 <result pre="al.The association of cytokines and micronutrients with hepatitis E virus" exact="infection" post="during pregnancy and the postpartum period in rural BangladeshAm"/>
 <result pre="micronutrients with hepatitis E virus infection during pregnancy and the" exact="postpartum" post="period in rural BangladeshAm J Trop Med Hyg20169420321126621563 109.Labrique"/>
 <result pre="R, Schulze K, Purcell R, West KP Jr, Nelson KE." exact="Immunologic" post="dysregulation and micronutrient deficiencies associated with risk of intrapartum"/>
 <result pre="Immunologic dysregulation and micronutrient deficiencies associated with risk of intrapartum" exact="hepatitis" post="E infections in pregnant Bangladeshi women, vol. 26: Federation"/>
 <result pre="and micronutrient deficiencies associated with risk of intrapartum hepatitis E" exact="infections" post="in pregnant Bangladeshi women, vol. 26: Federation of American"/>
 <result pre="E infections in pregnant Bangladeshi women, vol. 26: Federation of" exact="American" post="Societies for Experimental Biology; 2012. p. 127–4. https://www.fasebj.org/doi/10.1096/fasebj.26.1_supplement.127.4. 110.JiangTChristianPKhatrySKWuLWestKPJrMicronutrient"/>
 <result pre="pathogenesisLiver Int2008281190119918662274 113.RobinsonDPKleinSLPregnancy and pregnancy-associated hormones alter immune responses and" exact="disease" post="pathogenesisHorm Behav20126226327122406114 114.YangCYuWBiYLongFLiYWeiDHaoXSituJZhaoYHuangFIncreased oestradiol in hepatitis E virus-infected pregnant"/>
 <result pre="alter immune responses and disease pathogenesisHorm Behav20126226327122406114 114.YangCYuWBiYLongFLiYWeiDHaoXSituJZhaoYHuangFIncreased oestradiol in" exact="hepatitis" post="E virus-infected pregnant women promotes viral replicationJ Viral Hepat20182574275129345855"/>
 <result pre="Behav20126226327122406114 114.YangCYuWBiYLongFLiYWeiDHaoXSituJZhaoYHuangFIncreased oestradiol in hepatitis E virus-infected pregnant women promotes" exact="viral" post="replicationJ Viral Hepat20182574275129345855 115.BiYYangCYuWZhaoXZhaoCHeZJingSWangHHuangFPregnancy serum facilitates hepatitis E virus"/>
 <result pre="oestradiol in hepatitis E virus-infected pregnant women promotes viral replicationJ" exact="Viral" post="Hepat20182574275129345855 115.BiYYangCYuWZhaoXZhaoCHeZJingSWangHHuangFPregnancy serum facilitates hepatitis E virus replication in"/>
 <result pre="pregnant women promotes viral replicationJ Viral Hepat20182574275129345855 115.BiYYangCYuWZhaoXZhaoCHeZJingSWangHHuangFPregnancy serum facilitates" exact="hepatitis" post="E virus replication in vitroJ Gen Virol2015961055106125614592 116.SinghSDagaMKKumarAHusainSAKarPRole of"/>
 <result pre="oestrogen and its receptors in HEV-associated feto-maternal outcomesLiver Int20193963363929979823 117.BosePDDasBCKumarAGondalRKumarDKarPHigh" exact="viral" post="load and deregulation of the progesterone receptor signaling pathway:"/>
 <result pre="and deregulation of the progesterone receptor signaling pathway: association with" exact="hepatitis" post="E-related poor pregnancy outcomeJ Hepatol2011541107111321145845 118.AnderssonMIHughesJGordonFHIjazSDonatiMOf pigs and pregnancyLancet2008372119218926280"/>
 <result pre="119.RenouCGobertVLocherCMoumenATimbelyOSavaryJRoque-AfonsoAMcollab: Association Nationale des Hepato-Gastroenterologues des Hopitaux GProspective study of" exact="hepatitis" post="E virus infection among pregnant women in FranceVirol J2014116824716485"/>
 <result pre="Nationale des Hepato-Gastroenterologues des Hopitaux GProspective study of hepatitis E" exact="virus infection" post="among pregnant women in FranceVirol J2014116824716485 120.GouillyJChenQSiewieraJCartronGLevyCDuboisMAl-DaccakRIzopetJJabrane-FerratNEl CostaHGenotype specific"/>
 <result pre="des Hepato-Gastroenterologues des Hopitaux GProspective study of hepatitis E virus" exact="infection" post="among pregnant women in FranceVirol J2014116824716485 120.GouillyJChenQSiewieraJCartronGLevyCDuboisMAl-DaccakRIzopetJJabrane-FerratNEl CostaHGenotype specific"/>
 <result pre="pregnant women in FranceVirol J2014116824716485 120.GouillyJChenQSiewieraJCartronGLevyCDuboisMAl-DaccakRIzopetJJabrane-FerratNEl CostaHGenotype specific pathogenicity of" exact="hepatitis" post="E virus at the human maternal-fetal interfaceNat Commun20189474830420629 121.van"/>
 <result pre="functional and clinical relevanceEBioMedicine201611314227528267 122.HorvatitsTSchulze Zur WieschJLutgehetmannMLohseAWPischkeSThe clinical perspective on" exact="hepatitis" post="EViruses2019117617 123.DebingYGisaADallmeierKPischkeSBremerBMannsMWedemeyerHSuneethaPVNeytsJA mutation in the hepatitis E virus RNA"/>
 <result pre="WieschJLutgehetmannMLohseAWPischkeSThe clinical perspective on hepatitis EViruses2019117617 123.DebingYGisaADallmeierKPischkeSBremerBMannsMWedemeyerHSuneethaPVNeytsJA mutation in the" exact="hepatitis" post="E virus RNA polymerase promotes its replication and associates"/>
 <result pre="the methyltransferase region of the HEV genome in patients with" exact="acute" post="liver failureJ Clin Virol2017911428359977 125.TakahashiKOkamotoHAbeNKawakamiMMatsudaHMochidaSSakugawaHSuginoshitaYWatanabeSYamamotoKet al.Virulent strain of hepatitis"/>
 <result pre="with acute liver failureJ Clin Virol2017911428359977 125.TakahashiKOkamotoHAbeNKawakamiMMatsudaHMochidaSSakugawaHSuginoshitaYWatanabeSYamamotoKet al.Virulent strain of" exact="hepatitis" post="E virus genotype 3, JapanEmerg Infect Dis20091570470919402955 126.NanYYuYMaZKhattarSKFredericksenBZhangYJHepatitis E"/>
 <result pre="virus genotype 3, JapanEmerg Infect Dis20091570470919402955 126.NanYYuYMaZKhattarSKFredericksenBZhangYJHepatitis E virus inhibits" exact="type I" post="interferon induction by ORF1 productsJ Virol201488119241193225100852 127.OjhaNKLoleKSHepatitis E virus"/>
 <result pre="and inhibits its secretionMol Cell Biochem2016417758527170377 128.LinSYangYNanYMaZYangLZhangYJThe capsid protein of" exact="hepatitis" post="E virus inhibits interferon induction via its N-terminal arginine-rich"/>
 <result pre="induction via its N-terminal arginine-rich motifViruses201911111050 129.SurjitMVarshneyBLalSKThe ORF2 glycoprotein of" exact="hepatitis" post="E virus inhibits cellular NF-kappaB activity by blocking ubiquitination"/>
 <result pre="2003-2009Birth Defects Res A Clin Mol Teratol20108855155920564430 133.SperaAMEldinTKTosoneGOrlandoRAntiviral therapy for" exact="hepatitis" post="C: has anything changed for pregnant/lactating women?World J Hepatol2016855756527134703"/>
 <result pre="anything changed for pregnant/lactating women?World J Hepatol2016855756527134703 134.Dao ThiVLDebingYWuXRiceCMNeytsJMoradpourDGouttenoireJSofosbuvir inhibits" exact="hepatitis" post="E virus replication in vitro and results in an"/>
 <result pre="135.van der ValkMZaaijerHLKaterAPSchinkelJSofosbuvir shows antiviral activity in a patient with" exact="chronic hepatitis" post="E virus infectionJ Hepatol20176624224327702641 136.NishiyamaTKobayashiTJirintaiSKiiINagashimaSPrathiwi PrimadharsiniPNishizawaTOkamotoHScreening of novel drugs"/>
 <result pre="der ValkMZaaijerHLKaterAPSchinkelJSofosbuvir shows antiviral activity in a patient with chronic" exact="hepatitis" post="E virus infectionJ Hepatol20176624224327702641 136.NishiyamaTKobayashiTJirintaiSKiiINagashimaSPrathiwi PrimadharsiniPNishizawaTOkamotoHScreening of novel drugs"/>
 <result pre="virus infectionJ Hepatol20176624224327702641 136.NishiyamaTKobayashiTJirintaiSKiiINagashimaSPrathiwi PrimadharsiniPNishizawaTOkamotoHScreening of novel drugs for inhibiting" exact="hepatitis" post="E virus replicationJ Virol Methods201927011131004661 137.TodtDFrancoisCAnggakusumaBehrendtPEngelmannMKnegendorfLVieyresGWedemeyerHHartmannRPietschmannTet al.Antiviral activities of"/>
 <result pre="137.TodtDFrancoisCAnggakusumaBehrendtPEngelmannMKnegendorfLVieyresGWedemeyerHHartmannRPietschmannTet al.Antiviral activities of different interferon types and subtypes against" exact="Hepatitis" post="E virus replicationAntimicrob Agents Chemother2016602132213926787701 138.NanYMaZKannanHSteinDAIversenPIMengXJZhangYJInhibition of hepatitis E"/>
 <result pre="subtypes against Hepatitis E virus replicationAntimicrob Agents Chemother2016602132213926787701 138.NanYMaZKannanHSteinDAIversenPIMengXJZhangYJInhibition of" exact="hepatitis" post="E virus replication by peptide-conjugated morpholino oligomersAntivir Res201512013413926086884 139.NetzlerNEEnosi"/>
 <result pre="by peptide-conjugated morpholino oligomersAntivir Res201512013413926086884 139.NetzlerNEEnosi TuipulotuDVasudevanSGMackenzieJMWhitePAAntiviral candidates for treating" exact="hepatitis" post="E virus infectionAntimicrob Agents Chemother2019636e00003e0001930885901 140.NishiyamaTKobayashiTJirintaiSNagashimaSPrimadharsiniPPNishizawaTOkamotoHAntiviral candidates against the"/>
 <result pre="hepatitis E virus infectionAntimicrob Agents Chemother2019636e00003e0001930885901 140.NishiyamaTKobayashiTJirintaiSNagashimaSPrimadharsiniPPNishizawaTOkamotoHAntiviral candidates against the" exact="hepatitis" post="E virus (HEV) and their combinations inhibit HEV growth"/>
 <result pre="HEV growth in in vitroAntivir Res201917010457031362004 141.RacMWSheffieldJSPrevention and management of" exact="viral hepatitis" post="in pregnancyObstet Gynecol Clin N Am201441573592 142.collab: European Association"/>
 <result pre="growth in in vitroAntivir Res201917010457031362004 141.RacMWSheffieldJSPrevention and management of viral" exact="hepatitis" post="in pregnancyObstet Gynecol Clin N Am201441573592 142.collab: European Association"/>
 <result pre="the Study of the L: EASL clinical practice guidelines on" exact="hepatitis" post="E virus infectionJ Hepatol2018681256127129609832 143.WuTZhuFCHuangSJZhangXFWangZZZhangJXiaNSSafety of the hepatitis E"/>
 <result pre="guidelines on hepatitis E virus infectionJ Hepatol2018681256127129609832 143.WuTZhuFCHuangSJZhangXFWangZZZhangJXiaNSSafety of the" exact="hepatitis" post="E vaccine for pregnant women: a preliminary analysisHepatology201255203822161542 144.LiMLiSHeQLiangZWangLWangQWangLHepatitis"/>
 <result pre="analysisHepatology201255203822161542 144.LiMLiSHeQLiangZWangLWangQWangLHepatitis E-related adverse pregnancy outcomes and their prevention by" exact="hepatitis" post="E vaccine in a rabbit modelEmerg Microbes Infect201981066107531339458 145.ZamanKDudmanSStene-JohansenKQadriFYunusMSandbuSGurleyESOverboJJulinCHDembinskiJLet"/>
 <result pre="trial to assess the safety, immunogenicity and effectiveness of the" exact="hepatitis" post="E vaccine HEV 239 (Hecolin) in women of childbearing"/>
 <result pre="women of childbearing age in rural BangladeshBMJ Open202010e03370231959609 146.ChenXGongPWagnerALLiYWangGLuYIdentification of" exact="hepatitis" post="E virus subtype 4f in blood donors in Shanghai,"/>
</results>
